Literature DB >> 16959895

Control of NK cell functions by CD4+CD25+ regulatory T cells.

Natacha Ralainirina1, Aurélie Poli, Tatiana Michel, Linda Poos, Emmanuel Andrès, François Hentges, Jacques Zimmer.   

Abstract

Regulatory T cells (Treg) are key players in the maintenance of peripheral tolerance. As a result of suppressive effects on CD4+ and CD8+ effector T cells, Treg control the adaptive immune system and prevent autoimmunity. In addition, they inhibit B lymphocytes, dendritic cells, and monocytes/macrophages. It is interesting that several recent papers show that CD4+CD25+ Treg are also able to inhibit NK cells. Thus, Treg exert their control on immune responses from the onset (triggering of innate immune cells) to the effector phase of adaptive immunity (B and T cell-mediated responses). That Treg inhibit NK cells suggests that their uncontrolled activation might break self-tolerance and induce "innate" autoimmune pathology. Conversely, Treg-mediated suppression of NK cell functions might have negative effects, as these cells are important in defense against infections and cancer. It is conceivable that Treg might dampen efficient activation of NK cells in these diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959895     DOI: 10.1189/jlb.0606409

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  54 in total

Review 1.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

2.  Phosphoantigen-activated V gamma 2V delta 2 T cells antagonize IL-2-induced CD4+CD25+Foxp3+ T regulatory cells in mycobacterial infection.

Authors:  Guangming Gong; Lingyun Shao; Yunqi Wang; Crystal Y Chen; Dan Huang; Shuyu Yao; Ximei Zhan; Helene Sicard; Richard Wang; Zheng W Chen
Journal:  Blood       Date:  2008-11-03       Impact factor: 22.113

3.  Association of peripheral NK cell counts with Helios+ IFN-γ- Tregs in patients with good long-term renal allograft function.

Authors:  K Trojan; L Zhu; M Aly; R Weimer; N Bulut; C Morath; G Opelz; V Daniel
Journal:  Clin Exp Immunol       Date:  2017-03-13       Impact factor: 4.330

4.  Low-dose IL-2 induces CD56bright NK regulation of T cells via NKp44 and NKp46.

Authors:  S T Loughran; P A Power; S L McQuaid; P Maguire; A Szczygiel; P A Johnson
Journal:  Clin Exp Immunol       Date:  2020-02-13       Impact factor: 4.330

5.  T-regulatory lymphocytes in peripheral blood of gastric and colorectal cancer patients.

Authors:  Antoni M Szczepanik; Maciej Siedlar; Marek Sierzega; Dominika Goroszeniuk; Karolina Bukowska-Strakova; Antoni Czupryna; Jan Kulig
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

6.  Functional changes in regulatory T cells during an experimental infection with sparganum (plerocercofid of Spirometra mansoni).

Authors:  Hyung-Ran Kim; Su-Min Lee; Jong-Wha Won; Woosung Lim; Byung-In Moon; Hyun-Jong Yang; Ju-Young Seoh
Journal:  Immunology       Date:  2013-01       Impact factor: 7.397

Review 7.  Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy.

Authors:  Isabela Pedroza-Pacheco; Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

8.  Regulatory T cells suppress natural killer cells during plasmid DNA vaccination in mice, blunting the CD8+ T cell immune response by the cytokine TGFbeta.

Authors:  Kwesi Frimpong-Boateng; Nico van Rooijen; Ralf Geiben-Lynn
Journal:  PLoS One       Date:  2010-08-19       Impact factor: 3.240

Review 9.  The role of tregs in glioma-mediated immunosuppression: potential target for intervention.

Authors:  William Humphries; Jun Wei; John H Sampson; Amy B Heimberger
Journal:  Neurosurg Clin N Am       Date:  2010-01       Impact factor: 2.509

10.  Regulatory activity of azabisphosphonate-capped dendrimers on human CD4+ T cell proliferation enhances ex-vivo expansion of NK cells from PBMCs for immunotherapy.

Authors:  Damien Portevin; Mary Poupot; Olivier Rolland; Cédric-Olivier Turrin; Jean-Jacques Fournié; Jean-Pierre Majoral; Anne-Marie Caminade; Remy Poupot
Journal:  J Transl Med       Date:  2009-09-24       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.